Notch signaling regulates UNC5B to suppress endothelial proliferation, migration, junction activity, and retinal plexus branching.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 06 2024
Historique:
received: 21 03 2024
accepted: 07 06 2024
medline: 13 6 2024
pubmed: 13 6 2024
entrez: 12 6 2024
Statut: epublish

Résumé

Notch signaling guides vascular development and function by regulating diverse endothelial cell behaviors, including migration, proliferation, vascular density, endothelial junctions, and polarization in response to flow. Notch proteins form transcriptional activation complexes that regulate endothelial gene expression, but few of the downstream effectors that enable these phenotypic changes have been characterized in endothelial cells, limiting our understanding of vascular Notch activities. Using an unbiased screen of translated mRNA rapidly regulated by Notch signaling, we identified novel in vivo targets of Notch signaling in neonatal mouse brain endothelium, including UNC5B, a member of the netrin family of angiogenic-regulatory receptors. Endothelial Notch signaling rapidly upregulates UNC5B in multiple endothelial cell types. Loss or gain of UNC5B recapitulated specific Notch-regulated phenotypes. UNC5B expression inhibited endothelial migration and proliferation and was required for stabilization of endothelial junctions in response to shear stress. Loss of UNC5B partially or wholly blocked the ability of Notch activation to regulate these endothelial cell behaviors. In the developing mouse retina, endothelial-specific loss of UNC5B led to excessive vascularization, including increased vascular outgrowth, density, and branchpoint count. These data indicate that Notch signaling upregulates UNC5B as an effector protein to control specific endothelial cell behaviors and inhibit angiogenic growth.

Identifiants

pubmed: 38866944
doi: 10.1038/s41598-024-64375-z
pii: 10.1038/s41598-024-64375-z
doi:

Substances chimiques

Netrin Receptors 0
Receptors, Notch 0
Unc5b protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13603

Informations de copyright

© 2024. The Author(s).

Références

Nicholson, B. P. & Schachat, A. P. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 248, 915–930. https://doi.org/10.1007/s00417-010-1315-z (2010).
doi: 10.1007/s00417-010-1315-z pubmed: 20174816
Aiello, L. P. et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Engl. J. Med. 331, 1480–1487. https://doi.org/10.1056/NEJM199412013312203 (1994).
doi: 10.1056/NEJM199412013312203 pubmed: 7526212
Abu El-Asrar, A. M., Nawaz, M. I., Kangave, D., Mairaj Siddiquei, M. & Geboes, K. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J. Diabetes Res. 2013, 539658. https://doi.org/10.1155/2013/539658 (2013).
doi: 10.1155/2013/539658 pubmed: 23671874 pmcid: 3647558
Taimeh, Z., Loughran, J., Birks, E. J. & Bolli, R. Vascular endothelial growth factor in heart failure. Nat. Rev. Cardiol. 10, 519–530. https://doi.org/10.1038/nrcardio.2013.94 (2013).
doi: 10.1038/nrcardio.2013.94 pubmed: 23856679
Kerbel, R. S., Viloria-Petit, A., Okada, F. & Rak, J. Establishing a link between oncogenes and tumor angiogenesis. Mol. Med. 4, 286–295 (1998).
doi: 10.1007/BF03401737 pubmed: 9642680 pmcid: 2230380
Kopan, R. & Ilagan, M. X. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 137, 216–233. https://doi.org/10.1016/j.cell.2009.03.045 (2009).
doi: 10.1016/j.cell.2009.03.045 pubmed: 19379690 pmcid: 2827930
Groot, A. J. et al. Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins. Mol. Cell. Biol. 34, 2822–2832. https://doi.org/10.1128/MCB.00206-14 (2014).
doi: 10.1128/MCB.00206-14 pubmed: 24842903 pmcid: 4135574
Weber, S. et al. The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling. Development 138, 495–505. https://doi.org/10.1242/dev.055210 (2011).
doi: 10.1242/dev.055210 pubmed: 21205794 pmcid: 3014635
Mumm, J. S. et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell 5, 197–206. https://doi.org/10.1016/s1097-2765(00)80416-5 (2000).
doi: 10.1016/s1097-2765(00)80416-5 pubmed: 10882062
Schroeter, E. H., Kisslinger, J. A. & Kopan, R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382–386. https://doi.org/10.1038/30756 (1998).
doi: 10.1038/30756 pubmed: 9620803
Siebel, C. & Lendahl, U. Notch signaling in development, tissue homeostasis, and disease. Physiol. Rev. 97, 1235–1294. https://doi.org/10.1152/physrev.00005.2017 (2017).
doi: 10.1152/physrev.00005.2017 pubmed: 28794168
Gama-Norton, L. et al. Corrigendum: Notch signal strength controls cell fate in the haemogenic endothelium. Nat. Commun. 7, 10978. https://doi.org/10.1038/ncomms10978 (2016).
doi: 10.1038/ncomms10978 pubmed: 26939771 pmcid: 4785231
Bailis, W., Yashiro-Ohtani, Y. & Pear, W. S. Identifying direct Notch transcriptional targets using the GSI-washout assay. Methods Mol. Biol. 1187, 247–254. https://doi.org/10.1007/978-1-4939-1139-4_19 (2014).
doi: 10.1007/978-1-4939-1139-4_19 pubmed: 25053495
Palomero, T. et al. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Leukemia 20, 1279–1287. https://doi.org/10.1038/sj.leu.2404258 (2006).
doi: 10.1038/sj.leu.2404258 pubmed: 16688224
Weng, A. P. et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269–271. https://doi.org/10.1126/science.1102160 (2004).
doi: 10.1126/science.1102160 pubmed: 15472075
Gupta-Rossi, N. et al. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J. Biol. Chem. 276, 34371–34378. https://doi.org/10.1074/jbc.M101343200 (2001).
doi: 10.1074/jbc.M101343200 pubmed: 11425854
Krejci, A. & Bray, S. Notch activation stimulates transient and selective binding of Su(H)/CSL to target enhancers. Genes Dev 21, 1322–1327. https://doi.org/10.1101/gad.424607 (2007).
doi: 10.1101/gad.424607 pubmed: 17545467 pmcid: 1877745
Rand, M. D. et al. Calcium depletion dissociates and activates heterodimeric notch receptors. Mol. Cell. Biol. 20, 1825–1835. https://doi.org/10.1128/MCB.20.5.1825-1835.2000 (2000).
doi: 10.1128/MCB.20.5.1825-1835.2000 pubmed: 10669757 pmcid: 85363
Aster, J. C., Pear, W. S. & Blacklow, S. C. Notch signaling in leukemia. Annu. Rev. Pathol. 3, 587–613. https://doi.org/10.1146/annurev.pathmechdis.3.121806.154300 (2008).
doi: 10.1146/annurev.pathmechdis.3.121806.154300 pubmed: 18039126 pmcid: 5934586
Mosquera, J. M. et al. Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. Genes Chromosomes Cancer 52, 1075–1087. https://doi.org/10.1002/gcc.22102 (2013).
doi: 10.1002/gcc.22102 pubmed: 23999936 pmcid: 3889711
Wang, K. et al. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a gamma-secretase inhibitor. Clin. Cancer Res. 21, 1487–1496. https://doi.org/10.1158/1078-0432.CCR-14-1348 (2015).
doi: 10.1158/1078-0432.CCR-14-1348 pubmed: 25564152
Kofler, N. M. et al. Notch signaling in developmental and tumor angiogenesis. Genes Cancer 2, 1106–1116. https://doi.org/10.1177/1947601911423030 (2011).
doi: 10.1177/1947601911423030 pubmed: 22866202 pmcid: 3411124
Uyttendaele, H. et al. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122, 2251–2259 (1996).
doi: 10.1242/dev.122.7.2251 pubmed: 8681805
Naiche, L. A., Villa, S. R. & Kitajewski, J. K. Endothelial cell fate determination: A top notch job in vascular decision-making. Cold Spring Harb. Perspect. Med. https://doi.org/10.1101/cshperspect.a041183 (2022).
doi: 10.1101/cshperspect.a041183 pubmed: 35288401
Akil, A. et al. Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: An update and prospective. Front. Cell Dev. Biol. 9, 642352. https://doi.org/10.3389/fcell.2021.642352 (2021).
doi: 10.3389/fcell.2021.642352 pubmed: 33681228 pmcid: 7928398
Hellstrom, M. et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445, 776–780. https://doi.org/10.1038/nature05571 (2007).
doi: 10.1038/nature05571 pubmed: 17259973
Bentley, K. et al. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat. Cell Biol. 16, 309–321. https://doi.org/10.1038/ncb2926 (2014).
doi: 10.1038/ncb2926 pubmed: 24658686
Fang, J. S. et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat. Commun. 8, 2149. https://doi.org/10.1038/s41467-017-01742-7 (2017).
doi: 10.1038/s41467-017-01742-7 pubmed: 29247167 pmcid: 5732288
Mack, J. J. et al. NOTCH1 is a mechanosensor in adult arteries. Nat. Commun. 8, 1620. https://doi.org/10.1038/s41467-017-01741-8 (2017).
doi: 10.1038/s41467-017-01741-8 pubmed: 29158473 pmcid: 5696341
Ehling, M., Adams, S., Benedito, R. & Adams, R. H. Notch controls retinal blood vessel maturation and quiescence. Development 140, 3051–3061. https://doi.org/10.1242/dev.093351 (2013).
doi: 10.1242/dev.093351 pubmed: 23785053
Pontes-Quero, S. et al. High mitogenic stimulation arrests angiogenesis. Nat. Commun. 10, 2016. https://doi.org/10.1038/s41467-019-09875-7 (2019).
doi: 10.1038/s41467-019-09875-7 pubmed: 31043605 pmcid: 6494832
Jouve, C. et al. Notch signalling is required for cyclic expression of the hairy-like gene HES1 in the presomitic mesoderm. Development 127, 1421–1429. https://doi.org/10.1242/dev.127.7.1421 (2000).
doi: 10.1242/dev.127.7.1421 pubmed: 10704388
Taylor, K. L., Henderson, A. M. & Hughes, C. C. Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. Microvasc. Res. 64, 372–383. https://doi.org/10.1006/mvre.2002.2443 (2002).
doi: 10.1006/mvre.2002.2443 pubmed: 12453432
Iso, T., Kedes, L. & Hamamori, Y. HES and HERP families: Multiple effectors of the Notch signaling pathway. J. Cell Physiol. 194, 237–255. https://doi.org/10.1002/jcp.10208 (2003).
doi: 10.1002/jcp.10208 pubmed: 12548545
Fischer, A., Schumacher, N., Maier, M., Sendtner, M. & Gessler, M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 18, 901–911. https://doi.org/10.1101/gad.291004 (2004).
doi: 10.1101/gad.291004 pubmed: 15107403 pmcid: 395849
Shawber, C. J. et al. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J. Clin. Investig. 117, 3369–3382. https://doi.org/10.1172/JCI24311 (2007).
doi: 10.1172/JCI24311 pubmed: 17948123 pmcid: 2030453
Heinolainen, K. et al. VEGFR3 modulates vascular permeability by controlling VEGF/VEGFR2 signaling. Circ. Res. 120, 1414–1425. https://doi.org/10.1161/CIRCRESAHA.116.310477 (2017).
doi: 10.1161/CIRCRESAHA.116.310477 pubmed: 28298294 pmcid: 6959003
Zheng, L. C. et al. Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells. Oncotarget 8, 41348–41363. https://doi.org/10.18632/oncotarget.17298 (2017).
doi: 10.18632/oncotarget.17298 pubmed: 28489586 pmcid: 5522204
Iso, T. et al. Dll4-selective Notch signaling induces ephrinB2 gene expression in endothelial cells. Biochem. Biophys. Res. Commun. 341, 708–714. https://doi.org/10.1016/j.bbrc.2006.01.020 (2006).
doi: 10.1016/j.bbrc.2006.01.020 pubmed: 16430858
Phng, L. K. et al. Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev. Cell 16, 70–82. https://doi.org/10.1016/j.devcel.2008.12.009 (2009).
doi: 10.1016/j.devcel.2008.12.009 pubmed: 19154719 pmcid: 8114544
Lamar, E. et al. Nrarp is a novel intracellular component of the Notch signaling pathway. Genes Dev. 15, 1885–1899. https://doi.org/10.1101/gad.908101 (2001).
doi: 10.1101/gad.908101 pubmed: 11485984 pmcid: 312752
Ferrara, N., Gerber, H. P. & LeCouter, J. The biology of VEGF and its receptors. Nat. Med. 9, 669–676. https://doi.org/10.1038/nm0603-669 (2003).
doi: 10.1038/nm0603-669 pubmed: 12778165
Adams, R. H. & Alitalo, K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8, 464–478. https://doi.org/10.1038/nrm2183 (2007).
doi: 10.1038/nrm2183 pubmed: 17522591
Leonardo, E. D. et al. Vertebrate homologues of C. elegans UNC-5 are candidate netrin receptors. Nature 386, 833–838. https://doi.org/10.1038/386833a0 (1997).
doi: 10.1038/386833a0 pubmed: 9126742
Lu, X. et al. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 432, 179–186. https://doi.org/10.1038/nature03080 (2004).
doi: 10.1038/nature03080 pubmed: 15510105
Navankasattusas, S. et al. The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. Development 135, 659–667. https://doi.org/10.1242/dev.013623 (2008).
doi: 10.1242/dev.013623 pubmed: 18223200
Koch, A. W. et al. Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B. Dev. Cell 20, 33–46. https://doi.org/10.1016/j.devcel.2010.12.001 (2011).
doi: 10.1016/j.devcel.2010.12.001 pubmed: 21238923
Larrivee, B. et al. Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis. Genes Dev. 21, 2433–2447. https://doi.org/10.1101/gad.437807 (2007).
doi: 10.1101/gad.437807 pubmed: 17908930 pmcid: 1993874
Boye, K. et al. Endothelial Unc5B controls blood-brain barrier integrity. Nat. Commun. 13, 1169. https://doi.org/10.1038/s41467-022-28785-9 (2022).
doi: 10.1038/s41467-022-28785-9 pubmed: 35246514 pmcid: 8897508
Sanz, E. et al. Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proc. Natl. Acad. Sci. U. S. A. 106, 13939–13944. https://doi.org/10.1073/pnas.0907143106 (2009).
doi: 10.1073/pnas.0907143106 pubmed: 19666516 pmcid: 2728999
Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483–486. https://doi.org/10.1038/nature09002 (2010).
doi: 10.1038/nature09002 pubmed: 20445537
Swaminathan, B. et al. Endothelial Notch signaling directly regulates the small GTPase RND1 to facilitate Notch suppression of endothelial migration. Sci. Rep. 12, 1655. https://doi.org/10.1038/s41598-022-05666-1 (2022).
doi: 10.1038/s41598-022-05666-1 pubmed: 35102202 pmcid: 8804000
Walchli, T. et al. Wiring the vascular network with neural cues: A CNS perspective. Neuron 87, 271–296. https://doi.org/10.1016/j.neuron.2015.06.038 (2015).
doi: 10.1016/j.neuron.2015.06.038 pubmed: 26182414
Leslie, J. D. et al. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 134, 839–844. https://doi.org/10.1242/dev.003244 (2007).
doi: 10.1242/dev.003244 pubmed: 17251261
Phng, L. K. & Gerhardt, H. Angiogenesis: A team effort coordinated by notch. Dev. Cell 16, 196–208. https://doi.org/10.1016/j.devcel.2009.01.015 (2009).
doi: 10.1016/j.devcel.2009.01.015 pubmed: 19217422
Nowak-Sliwinska, P. et al. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21, 425–532. https://doi.org/10.1007/s10456-018-9613-x (2018).
doi: 10.1007/s10456-018-9613-x pubmed: 29766399 pmcid: 6237663
He, L. et al. Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types. Sci. Data 5, 180160. https://doi.org/10.1038/sdata.2018.160 (2018).
doi: 10.1038/sdata.2018.160 pubmed: 30129931 pmcid: 6103262
Seebach, J. et al. Regulation of endothelial barrier function during flow-induced conversion to an arterial phenotype. Cardiovasc. Res. 75, 596–607. https://doi.org/10.1016/j.cardiores.2007.04.017 (2007).
doi: 10.1016/j.cardiores.2007.04.017 pubmed: 17531214
Gariano, R. F. & Gardner, T. W. Retinal angiogenesis in development and disease. Nature 438, 960–966. https://doi.org/10.1038/nature04482 (2005).
doi: 10.1038/nature04482 pubmed: 16355161
Murtaugh, L. C., Stanger, B. Z., Kwan, K. M. & Melton, D. A. Notch signaling controls multiple steps of pancreatic differentiation. Proc. Natl. Acad. Sci. U. S. A. 100, 14920–14925. https://doi.org/10.1073/pnas.2436557100 (2003).
doi: 10.1073/pnas.2436557100 pubmed: 14657333 pmcid: 299853
Izumi, N. et al. Fbxw7 controls angiogenesis by regulating endothelial Notch activity. PLoS One 7, e41116. https://doi.org/10.1371/journal.pone.0041116 (2012).
doi: 10.1371/journal.pone.0041116 pubmed: 22848434 pmcid: 3407154
Lobov, I. B. et al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc. Natl. Acad. Sci. U. S. A. 104, 3219–3224. https://doi.org/10.1073/pnas.0611206104 (2007).
doi: 10.1073/pnas.0611206104 pubmed: 17296940 pmcid: 1805530
Suchting, S. et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl. Acad. Sci. U. S. A. 104, 3225–3230. https://doi.org/10.1073/pnas.0611177104 (2007).
doi: 10.1073/pnas.0611177104 pubmed: 17296941 pmcid: 1805603
Krebs, L. T. et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14, 1343–1352 (2000).
doi: 10.1101/gad.14.11.1343 pubmed: 10837027 pmcid: 316662
McCue, S. et al. Shear stress regulates forward and reverse planar cell polarity of vascular endothelium in vivo and in vitro. Circ. Res. 98, 939–946. https://doi.org/10.1161/01.RES.0000216595.15868.55 (2006).
doi: 10.1161/01.RES.0000216595.15868.55 pubmed: 16527990
Davies, P. F., Civelek, M., Fang, Y. & Fleming, I. The atherosusceptible endothelium: Endothelial phenotypes in complex haemodynamic shear stress regions in vivo. Cardiovasc. Res. 99, 315–327. https://doi.org/10.1093/cvr/cvt101 (2013).
doi: 10.1093/cvr/cvt101 pubmed: 23619421 pmcid: 3695748
Furtado, J. et al. Netrin-1 binding to Unc5B regulates Blood-Retina Barrier integrity. bioRxiv https://doi.org/10.1101/2023.01.21.525006 (2023).
doi: 10.1101/2023.01.21.525006 pubmed: 36711611 pmcid: 9882365
Alabi, R. O. et al. ADAM10-dependent signaling through Notch1 and Notch4 controls development of organ-specific vascular beds. Circ. Res. 119, 519–531. https://doi.org/10.1161/CIRCRESAHA.115.307738 (2016).
doi: 10.1161/CIRCRESAHA.115.307738 pubmed: 27354212 pmcid: 4975635
James, A. C. et al. Notch4 reveals a novel mechanism regulating Notch signal transduction. Biochim. Biophys. Acta 1843, 1272–1284. https://doi.org/10.1016/j.bbamcr.2014.03.015 (2014).
doi: 10.1016/j.bbamcr.2014.03.015 pubmed: 24667410
Gaengel, K. et al. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev. Cell 23, 587–599. https://doi.org/10.1016/j.devcel.2012.08.005 (2012).
doi: 10.1016/j.devcel.2012.08.005 pubmed: 22975327
National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals., Institute for Laboratory Animal Research (U.S.) & National Academies Press (U.S.). Guide for the care and use of laboratory animals. 8th edn, (National Academies Press, 2011).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https://doi.org/10.1186/s13059-014-0550-8 (2014).
doi: 10.1186/s13059-014-0550-8 pubmed: 25516281 pmcid: 4302049
Daneshjou, N. et al. Rac1 functions as a reversible tension modulator to stabilize VE-cadherin trans-interaction. J. Cell Biol. 208, 23–32. https://doi.org/10.1083/jcb.201409108 (2015).
doi: 10.1083/jcb.201409108 pubmed: 25559184 pmcid: 4284224
Nadeem, T., Bogue, W., Bigit, B. & Cuervo, H. Deficiency of Notch signaling in pericytes results in arteriovenous malformations. JCI Insight https://doi.org/10.1172/jci.insight.125940 (2020).
doi: 10.1172/jci.insight.125940 pubmed: 33148887 pmcid: 7710269

Auteurs

Qanber Raza (Q)

Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 1853 W Polk St, Rm 522 (MC 901), Chicago, IL, 60612, USA.

Taliha Nadeem (T)

Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 1853 W Polk St, Rm 522 (MC 901), Chicago, IL, 60612, USA.

Seock-Won Youn (SW)

Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 1853 W Polk St, Rm 522 (MC 901), Chicago, IL, 60612, USA.

Bhairavi Swaminathan (B)

Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 1853 W Polk St, Rm 522 (MC 901), Chicago, IL, 60612, USA.

Ahana Gupta (A)

Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 1853 W Polk St, Rm 522 (MC 901), Chicago, IL, 60612, USA.

Timothy Sargis (T)

Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 1853 W Polk St, Rm 522 (MC 901), Chicago, IL, 60612, USA.

Jing Du (J)

Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 1853 W Polk St, Rm 522 (MC 901), Chicago, IL, 60612, USA.

Henar Cuervo (H)

Centro Nacional de Investigaciones Cardiovasculares Carlos III- CNIC- (F.S.P), Madrid, Spain.

Anne Eichmann (A)

Yale School of Medicine, New Haven, CT, USA.

Susan L Ackerman (SL)

University of San Diego, San Diego, CA, USA.

L A Naiche (LA)

Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 1853 W Polk St, Rm 522 (MC 901), Chicago, IL, 60612, USA. naiche@uic.edu.

Jan Kitajewski (J)

Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 1853 W Polk St, Rm 522 (MC 901), Chicago, IL, 60612, USA.
University of Illinois Cancer Center, Chicago, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH